These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 7538746
1. [Clinical, urodynamic, and radiologic results in the study of prostatism with the PURR measure (passive urethral resistance ratio)]. Adot Zurbano JM, Salinas Casado J, Virseda Chamorro M, Esteban Fuertes M, Samblas García R, Resel Estévez L. Arch Esp Urol; 1995 Mar; 48(2):162-72. PubMed ID: 7538746 [Abstract] [Full Text] [Related]
2. [A comparative study of different urodynamic methods used in the diagnosis of lower urinary tract obstruction in men]. Virseda Chamorro M, Salinas Casado J, Adot Zurbano JM, Esteban Fuertes M, Samblas García R, Resel Estévez L. Arch Esp Urol; 1995 May; 48(4):369-80. PubMed ID: 7598548 [Abstract] [Full Text] [Related]
3. Detrusor contraction duration as a urodynamic parameter of bladder outlet obstruction for evaluating men with lower urinary tract symptoms. Ameda K, Steele GS, Sullivan MP, Stember D, Yalla SV. J Urol; 1998 Aug; 160(2):482-6. PubMed ID: 9679903 [Abstract] [Full Text] [Related]
4. Comparison of passive urethral resistance relation and urethral resistance factor in analysis of bladder outlet obstruction in patients with benign prostatic enlargement. Rosier PF, de la Rosette JJ, de Wildt MJ, Debruyne FM, Wijkstra H. Neurourol Urodyn; 1996 Aug; 15(1):1-10; discussion 10-5. PubMed ID: 8696351 [Abstract] [Full Text] [Related]
5. [Incidence of the form and caliber of urethral resistance. Evaluation for a normal masculine urethra and in cases of obstruction due to prostatic hypertrophy]. Glémain P, Cordonnier JP, Bochereau G, Baron M, Le Normand L, Buzelin JM. Prog Urol; 1993 Dec; 3(6):995-1015; discussion 1006-8. PubMed ID: 7508314 [Abstract] [Full Text] [Related]
9. Reasons for the weak correlation between prostate volume and urethral resistance parameters in patients with prostatism. Bosch JL, Kranse R, van Mastrigt R, Schröder FH. J Urol; 1995 Mar; 153(3 Pt 1):689-93. PubMed ID: 7532234 [Abstract] [Full Text] [Related]
10. Predictors of short-term overactive bladder symptom improvement after transurethral resection of prostate in men with benign prostatic obstruction. Zhao YR, Liu WZ, Guralnick M, Niu WJ, Wang Y, Sun G, Xu Y. Int J Urol; 2014 Oct; 21(10):1035-40. PubMed ID: 24825248 [Abstract] [Full Text] [Related]
11. Correlation between micturitional urethral pressure profile and pressure-flow criteria in bladder outlet obstruction. DuBeau CE, Sullivan MP, Cravalho E, Resnick NM, Yalla SV. J Urol; 1995 Aug; 154(2 Pt 1):498-503. PubMed ID: 7541866 [Abstract] [Full Text] [Related]
12. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. Oelke M, Baard J, Wijkstra H, de la Rosette JJ, Jonas U, Höfner K. Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657 [Abstract] [Full Text] [Related]
13. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial. Dmochowski R, Roehrborn C, Klise S, Xu L, Kaminetsky J, Kraus S. J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847 [Abstract] [Full Text] [Related]
14. [Correlation coefficient of urodynamic data used in prostatism]. Salinas Casado J, Vírseda Chamorro M, Adot JM, Esteban Fuertes M, Resel Estévez L. Arch Esp Urol; 1997 Mar; 50(6):573-8. PubMed ID: 9412356 [Abstract] [Full Text] [Related]
15. [Doxazosin treatment of disorders of the voiding phase in benign prostatic hyperplasia]. Esteban Fuertes M, Salinas Casado J, Virseda Chamorro M, Ramírez Fernández JC, Salomon Moh'd S, Luengo Alpuente S, Resel Estévez L. Arch Esp Urol; 1997 Dec; 50(10):1057-66. PubMed ID: 9494194 [Abstract] [Full Text] [Related]